|
Volumn 8, Issue 2, 2005, Pages 99-109
|
Postmenopausal osteoporosis: Therapeutic options
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALENDRONIC ACID;
ANABOLIC AGENT;
ANDROGEN;
BISPHOSPHONIC ACID DERIVATIVE;
CALCIUM;
CONJUGATED ESTROGEN;
DROSPIRENONE;
DYDROGESTERONE;
ESTRADIOL;
ESTROGEN;
ESTROGEN RECEPTOR ALPHA;
ESTROGEN RECEPTOR BETA;
GESTAGEN;
GLUCOCORTICOID;
LEVONORGESTREL;
MEDROXYPROGESTERONE ACETATE;
MEGESTROL;
METHYLTESTOSTERONE;
NORETHISTERONE;
ORAL CONTRACEPTIVE AGENT;
PARATHYROID HORMONE;
PARATHYROID HORMONE[1-34];
PHYTOESTROGEN;
RALOXIFENE;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
SEX HORMONE BINDING GLOBULIN;
STRONTIUM RANELATE;
TIBOLONE;
TRIMEGESTONE;
VITAMIN D;
ADULT;
AGED;
ALCOHOL CONSUMPTION;
AVASCULAR NECROSIS;
BONE DENSITY;
BONE MASS;
BONE MINERAL;
BONE STRENGTH;
COFFEE;
CONFERENCE PAPER;
CORTICOSTEROID INDUCED OSTEOPOROSIS;
DEEP VEIN THROMBOSIS;
DENTAL HEALTH;
DIARRHEA;
DIET SUPPLEMENTATION;
DIETARY INTAKE;
DUAL ENERGY X RAY ABSORPTIOMETRY;
ESTROGEN THERAPY;
EYE INFLAMMATION;
FEMALE;
GASTROINTESTINAL TOXICITY;
HORMONAL THERAPY;
HORMONE SUBSTITUTION;
HOT FLUSH;
HUMAN;
LEG CRAMP;
LOW DRUG DOSE;
MEDICAL DECISION MAKING;
MOUSE;
NAUSEA;
NONHUMAN;
ORAL CONTRACEPTION;
OSTEOPOROSIS;
PERICARDIAL DISEASE;
PERIODONTAL DISEASE;
PHYSICAL ACTIVITY;
POSTMENOPAUSE OSTEOPOROSIS;
PRIORITY JOURNAL;
REFLUX ESOPHAGITIS;
RISK BENEFIT ANALYSIS;
RISK FACTOR;
SKIN IRRITATION;
STEROID THERAPY;
STROKE;
TREATMENT INDICATION;
ULTRASOUND;
VERTEBRA FRACTURE;
VITAMIN D DEFICIENCY;
AGE FACTORS;
ANABOLIC AGENTS;
ANIMALS;
BONE DENSITY;
CALCIUM;
CONTRACEPTIVES, ORAL;
DIPHOSPHONATES;
DISEASE MODELS, ANIMAL;
ESTROGEN REPLACEMENT THERAPY;
FEMALE;
FRACTURES, BONE;
HUMANS;
NORPREGNENES;
ORGANOMETALLIC COMPOUNDS;
OSTEOPOROSIS, POSTMENOPAUSAL;
RISK FACTORS;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
SPINAL FRACTURES;
THIOPHENES;
VITAMIN D;
|
EID: 20844449391
PISSN: 13697137
EISSN: None
Source Type: Journal
DOI: 10.1080/13697130500118027 Document Type: Conference Paper |
Times cited : (24)
|
References (0)
|